Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Concentrix Corporation (CNXC) Stock Forecast & Price Prediction United States | NASDAQ | Technology | Information Technology Services
$27.38
-0.44 (-1.58%)Did CNXC Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Concentrix is one of their latest high-conviction picks.
Based on our analysis of 5 Wall Street analysts, CNXC has a bullish consensus with a median price target of $39.00 (ranging from $32.00 to $55.00). The overall analyst rating is Strong Buy (8.5/10). Currently trading at $27.38, the median forecast implies a 42.4% upside. This outlook is supported by 3 Buy, 1 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Luke Morison at Canaccord Genuity, projecting a 100.9% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for CNXC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 25, 2026 | Barrington Research | Vincent Colicchio | Outperform | Maintains | $38.00 |
| Mar 25, 2026 | Canaccord Genuity | Luke Morison | Buy | Maintains | $55.00 |
| Mar 25, 2026 | Baird | David Koning | Outperform | Maintains | $40.00 |
| Mar 17, 2026 | Barrington Research | Outperform | Maintains | $N/A | |
| Jan 12, 2026 | Barrington Research | Outperform | Maintains | $N/A | |
| Nov 20, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Sep 29, 2025 | Baird | Outperform | Maintains | $N/A | |
| Sep 26, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Sep 26, 2025 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Sep 24, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Sep 23, 2025 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Sep 18, 2025 | Baird | Outperform | Maintains | $N/A | |
| Jun 30, 2025 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Jun 27, 2025 | B of A Securities | Neutral | Maintains | $N/A | |
| Jun 27, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Jun 26, 2025 | Baird | Outperform | Maintains | $N/A | |
| Jun 24, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Jun 9, 2025 | B of A Securities | Neutral | Maintains | $N/A | |
| Mar 27, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Mar 27, 2025 | B of A Securities | Neutral | Maintains | $N/A |
The following stocks are similar to Concentrix based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Concentrix Corporation has a market capitalization of $1.67B with a P/E ratio of 8.3x. The company generates $9.95B in trailing twelve-month revenue with a -13.3% profit margin.
Revenue growth is +5.4% quarter-over-quarter, while maintaining an operating margin of +6.2% and return on equity of -38.9%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Provides customer engagement and management services.
Concentrix Corporation generates revenue by offering technology-enabled customer engagement and management solutions. Its services include optimizing customer experience processes, technology innovation, and analytics, catering to a wide range of industries such as technology, retail, and healthcare.
Founded in 2004 and headquartered in the United States, Concentrix operates globally, with a presence in major markets including the Philippines, India, and France. The company is recognized as a leader in the information technology services sector and plays a significant role in the business process outsourcing industry.
Technology
Information Technology Services
450,000
Mr. Christopher A. Caldwell
United States
2017
INOD's first-quarter results show AI demand turning into profits: record $90.1M revenues, 28% EBITDA margin and $37.3M operating cash flow.
Concentrix has been named to the Fortune 500ยฎ list for the third consecutive year, highlighting its growth, performance, and reputation as a reliable business partner.
Concentrix's consistent Fortune 500 ranking signals strong growth and stability, enhancing its credibility and attractiveness to investors seeking reliable companies.
Concentrix (NASDAQ: CNXC) has enhanced its partnership with NiCE and achieved Platinum status in NiCE's 360 Partner Program.
Concentrix's expanded partnership with NiCE and achieving Platinum status may enhance its service offerings, potentially driving revenue growth and increasing investor confidence.
Concentrix Corporation (NASDAQ: CNXC) will have its senior management team participate in several upcoming investor conferences.
Concentrix's participation in investor conferences signals engagement with shareholders, potentially boosting investor confidence and impacting stock performance.
Investors should monitor CNXC stock due to recent activity in the options market, indicating potential significant movements.
Increased activity in CNXC options suggests heightened investor interest or volatility expectations, potentially signaling future price movements that could impact stock performance.
Taiwan Semiconductor shows strong growth potential, while Concentrix faces challenges but provides a high dividend yield.
Taiwan Semiconductor's growth potential signals strong future returns, while Concentrix's high dividend yield may attract income-focused investors amid its challenges.
Concentrix reported Q3 adjusted earnings of $2.61 per share, missing estimates of $2.65. Revenue was $2.500 billion, a 5.4% Y/Y increase, surpassing expectations of $2.492 billion.
Concentrix's earnings miss may signal potential operational issues, while revenue growth exceeding expectations indicates strong demand. Both factors could influence stock performance and investor sentiment.
Based on our analysis of 5 Wall Street analysts, Concentrix Corporation (CNXC) has a median price target of $39.00. The highest price target is $55.00 and the lowest is $32.00.
According to current analyst ratings, CNXC has 3 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $27.38. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict CNXC stock could reach $39.00 in the next 12 months. This represents a 42.4% increase from the current price of $27.38. Please note that this is a projection by Wall Street analysts and not a guarantee.
Concentrix Corporation generates revenue by offering technology-enabled customer engagement and management solutions. Its services include optimizing customer experience processes, technology innovation, and analytics, catering to a wide range of industries such as technology, retail, and healthcare.
The highest price target for CNXC is $55.00 from Luke Morison at Canaccord Genuity, which represents a 100.9% increase from the current price of $27.38.
The lowest price target for CNXC is $32.00 from at , which represents a 16.9% increase from the current price of $27.38.
The overall analyst consensus for CNXC is bullish. Out of 5 Wall Street analysts, 3 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $39.00.
Stock price projections, including those for Concentrix Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.